COMPARISON OF DIFFERENT REMISSION INDICES IN PATIENTS WITH PSORIATIC ARTHRITIS: A POST HOC ANALYSIS OF DATA FROM PHASE 3 TOFACITINIB STUDIES

被引：0
|
作者：
Schneeberger, E. [1 ]
Citera, G. [1 ]
Nash, P. [2 ]
Smolen, J. S. [3 ]
Mease, P. J. [4 ,5 ]
Soriano, E. [6 ]
Helling, C. [7 ]
Szumski, A. E. [8 ]
Mundayat, R. [9 ]
Graham, D. [10 ]
Ponce de Leon, D. [11 ]
机构：
[1] Inst Rehabil Psicofis, Buenos Aires, DF, Argentina
[2] Griffith Univ, Brisbane, Qld, Australia
[3] Med Univ Vienna, Vienna, Austria
[4] Swedish Med Ctr, Seattle, WA USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[7] Pfizer Inc, Buenos Aires, DF, Argentina
[8] Pfizer Inc, Collegeville, PA USA
[9] Pfizer Inc, New York, NY USA
[10] Pfizer Inc, Groton, CT 06340 USA
[11] Pfizer Inc, Lima, Peru
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.948
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0831
引用
收藏
页码：1716 / 1717
页数：2
相关论文
共 50 条
  • [41] EFFECT OF TOFACITINIB ON PATIENT-REPORTED OUTCOMES IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES
    Strand, V.
    de Vlam, K.
    Covarrubias-Cobos, J. A.
    Mease, P. J.
    Gladman, D. D.
    Hendrikx, T.
    Kudlacz, E.
    Graham, D.
    Wu, J.
    Chen, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1335 - 1336
  • [42] COMPARISON OF DIFFERENT REMISSION TARGETS IN PATIENTS WITH PSORIATIC ARTHRITIS AND EVALUATION OF THEIR PROGNOSTIC VALUE
    Coates, L. C.
    Aikman, L.
    Szumski, A.
    Chhabra, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 939 - 939
  • [43] Effect of Tofacitinib on Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis: Results from 2 Phase 3 Studies
    Strand, Vibeke
    de Vlam, Kurt
    Covarrubias-Cobos, Jose A.
    Mease, Philip J.
    Gladman, Dafna D.
    Hendrikx, Thijs
    Kudlacz, Elizabeth
    Graham, Daniela
    Wu, Joseph
    Cappelleri, Joseph C.
    Hsu, Ming-Ann
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [44] COMPARISON OF TOFACITINIB EFFICACY IN PATIENTS WITH MODERATE VS SEVERE RHEUMATOID ARTHRITIS: POOLED ANALYSIS OF PHASE 3 STUDIES
    Schwartzman, S.
    Sunkureddi, P.
    Takiya, L.
    Snyder, M.
    Fan, H.
    Lukic, T.
    Roberts, J.
    Rigby, W. F. C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1202 - 1203
  • [45] Comparison of Tofacitinib Efficacy in Patients with Moderate Vs Severe Rheumatoid Arthritis: Pooled Analysis of Phase 3 Studies
    Schwartzman, Sergio
    Sunkureddi, Prashanth
    Takiya, Liza
    Snyder, Mark
    Fan, Haiyun
    Lukic, Tatjana
    Roberts, Jacqui
    Rigby, William F. C.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [46] Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
    Taylor, Peter C.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Young, Pamela
    Germino, Rebecca
    Merola, Joseph F.
    Yosipovitch, Gil
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (05) : 2614 - 2620
  • [47] Relationships Between Dermatologic Symptoms and Health-related Quality of Life in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
    Taylor, Peter C.
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Young, Pamela
    Germino, Rebecca
    Merola, Joseph
    Yosipovitch, Gil
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3803 - 3805
  • [48] Relationships Between Minimal Disease Activity and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
    Helliwell, Philip
    Bushmakin, Andrew
    Gladman, Dafna
    FitzGerald, Oliver
    Fallon, Lara
    Cappelleri, Joseph
    Hsu, Ming-Ann
    Coates, Laura
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] Evaluation of Disease Activity in Patients with Rheumatoid Arthritis Treated with Tofacitinib By RAPID3: An Analysis of Data from 6 Phase 3 Studies
    Bergman, Martin J.
    Yazici, Yusuf
    Dikranian, Ara
    Bourret, Jeffrey
    Zang, Chuanbo
    Mojcik, Christopher F.
    Bananis, Eustratios
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [50] Baseline Structural Damage Predicts Response to Abatacept in Patients with Psoriatic Arthritis: A Post Hoc Analysis from a Phase III Study
    Schett, Georg
    Lehman, T.
    Ahmad, H. A.
    Johnsen, A.
    Banerjee, S.
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345